← FDA Drug Approvals (Drugs@FDA)

PYQUVI

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUCTA · Approved 2025-06-30

Drug application

FDA Application #

ANDA219417

Application type

Abbreviated New Drug Application (Generic)

Brand name

PYQUVI

Generic name

DEFLAZACORT

Active ingredients

DEFLAZACORT

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AUCTA

Manufacturer

Aucta Pharmaceuticals, Inc.

First approval

2025-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown